METROPOLITAN LIFE INSURANCE CO/NY - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 107 filers reported holding THERAVANCE INC in Q2 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$638,000
+46.7%
60,5760.0%0.01%
+66.7%
Q3 2015$435,000
-60.3%
60,5760.0%0.00%
-62.5%
Q2 2015$1,095,000
+9.8%
60,576
-4.5%
0.01%
+14.3%
Q1 2015$997,000
+11.0%
63,4400.0%0.01%
+16.7%
Q4 2014$898,000
-17.2%
63,4400.0%0.01%
-25.0%
Q3 2014$1,084,000
-42.6%
63,4400.0%0.01%
-38.5%
Q2 2014$1,889,000
+1024.4%
63,440
+1071.3%
0.01%
+1200.0%
Q1 2014$168,000
-13.0%
5,4160.0%0.00%0.0%
Q4 2013$193,000
-12.7%
5,4160.0%0.00%
-50.0%
Q3 2013$221,000
+12.8%
5,416
+6.4%
0.00%0.0%
Q2 2013$196,0005,0880.00%
Other shareholders
THERAVANCE INC shareholders Q2 2015
NameSharesValueWeighting ↓
Baupost Group 20,144,301$718,144,00020.35%
Litespeed Management, L.L.C. 1,636,994$58,359,0008.44%
Realm Partners LLC 240,794$8,585,0007.27%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,828,059$100,820,0004.97%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,456,503$265,824,0003.15%
SECTORAL ASSET MANAGEMENT INC 1,973,188$70,344,0003.03%
Foundation Asset Management, LP 221,796$7,907,0002.06%
Rhenman & Partners Asset Management AB 132,000$4,706,0001.84%
BB BIOTECH AG 888,244$31,666,0001.69%
HealthCor Management, L.P. 725,000$25,846,0001.57%
View complete list of THERAVANCE INC shareholders